Guéry J C, Adorini L
Roche Milano Ricerche, Italy.
Crit Rev Immunol. 1993;13(3-4):195-206.
Administration of major histocompatibility complex (MHC) class II-binding synthetic peptides can induce selective immunosuppression via different mechanisms of action. In this review four different ways to induce selective immunosuppression by peptide administration will be examined: MHC blockade, T cell receptor (TCR) antagonism, induction of peripheral tolerance, and activation of regulatory cells. These approaches to selective immunosuppression target three types of cells: antigen-presenting cells, antigen-specific T cells, and regulatory T cells. Understanding these forms of immunosuppression will provide new insights in basic immunology and may offer strategies for selective immunointervention in autoimmune diseases, allograft rejection, and allergy.
给予主要组织相容性复合体(MHC)II类结合合成肽可通过不同作用机制诱导选择性免疫抑制。在本综述中,将探讨通过肽给药诱导选择性免疫抑制的四种不同方式:MHC阻断、T细胞受体(TCR)拮抗、外周耐受诱导和调节性细胞激活。这些选择性免疫抑制方法针对三种类型的细胞:抗原呈递细胞、抗原特异性T细胞和调节性T细胞。了解这些免疫抑制形式将为基础免疫学提供新的见解,并可能为自身免疫性疾病、同种异体移植排斥反应和过敏的选择性免疫干预提供策略。